Rabbit Monoclonal Antibody Service Using B Cell Cloning Technology

RevMAb offers a number of different rabbit and goat monoclonal antibody development and production services. We develop monoclonal antibodies directly from the isolated B Cells of immunized animals using our proprietary technology. The B cells are grown in 96-well plates and their supernatants are screened to identify the B cell clones that produce antigen specific antibodies for desired applications. The antibodies are recombinantly produced by cloning their H and L chain cDNAs and expressing them in mammalian cells. Our technology has so far been successfully applied to produce a various range of antibodies with high specificity and affinity for research, diagnostic, and therapeutic use. Please contact us for more information.

Custom Services

Custom Antibody Development

  • Rabbit Monoclonal Antibody
  • Methyl/Acetyl/Phosphorylation Antibody 
  • Point Mutation Specific Antibody
  • Anti-Idiotype Antibody 
Fast protocol: 8-12 weeks
Regular protocol: 4-5 months
Antibody Production and Characterization

  • Transient Expression
  • Stable Expression
  • Antibody Characterization
Assay testing service: Luminex Multiplex, Flow Cytometry, ELISA, IHC, ICC, IF, and IP  
Antibody Engineering

  • Chimeric Antibody Construction and Production Service
  • Mouse And Rabbit Antibody Humanization Service
  • Therapeutic Antibody Service
For More Information Email: info@revmab.com or Submit an Inquiry 




Gui X, Deng M, Song H, Chen Y, Xie J, Li Z, He L, Huang F, Xu Y, Anami Y, Yu H, Yu C, Li L, Yuan Z, Xu X, Wang Q, Chai Y, Huang T, Shi Y, Tsuchikama K, Liao XC, Xia N, Gao GF, Zhang N, Zhang CC, An Z., Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development. Cancer Immunol Res. 2019 Aug;7(8):1244-1257.

Partners & collaborators

University of North Carolina

The University of Texas Health Science Center at Houston

University of Michigan

Baylor College of Medicine

University of Washington

Dana-Farber Cancer Institute

University College London

Royal National Orthopaedic Hospital